71 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31271267 | [18F]fluorodeoxyglucose-positron emission tomography and glucose-transporter type 1 expression in untreated primary small bowel adenocarcinoma. | 2021 Sep | 1 |
2 | 32739099 | Lenticular nuclei to thalamic ratio on PET is useful for diagnosis of GLUT1 deficiency syndrome. | 2021 Jan | 1 |
3 | 32886301 | [18F]FDG Uptake in Adipose Tissue Is Not Related to Inflammation in Type 2 Diabetes Mellitus. | 2021 Feb | 1 |
4 | 33278334 | Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT-1: Influence on 18 F-FDG PET Uptake. | 2021 May | 3 |
5 | 33725499 | HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging. | 2021 May-Jun | 3 |
6 | 33750337 | Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients. | 2021 Mar 9 | 1 |
7 | 34049629 | A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers. | 2021 Jul 4 | 1 |
8 | 34422129 | 18F-FDG PET/CT Evaluation of Thymomas: a Pictorial Review. | 2021 Aug | 1 |
9 | 34572860 | Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography. | 2021 Sep 15 | 2 |
10 | 32028659 | Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma. | 2020 Feb 3 | 2 |
11 | 32269845 | Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool. | 2020 Mar | 2 |
12 | 32626532 | Overexpression of METTL3 associated with the metabolic status on 18F-FDG PET/CT in patients with Esophageal Carcinoma. | 2020 | 2 |
13 | 30431083 | EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis. | 2019 Jan | 1 |
14 | 30682160 | In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes. | 2019 | 2 |
15 | 30799682 | PET Imaging of Hepatocellular Carcinomas: 18F-Fluoropropionic Acid as a Complementary Radiotracer for 18F-Fluorodeoxyglucose. | 2019 Jan-Dec | 1 |
16 | 31186081 | ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway. | 2019 Jul | 1 |
17 | 29550845 | Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancer. | 2018 Jan-Apr | 1 |
18 | 29913554 | Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia. | 2018 Sep | 1 |
19 | 30083516 | Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma. | 2018 | 1 |
20 | 30864374 | Sodium-glucose cotransporters: new targets of cancer therapy? | 2018 Dec 1 | 2 |
21 | 28410229 | In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT. | 2017 May 23 | 2 |
22 | 28412205 | SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas. | 2017 Jul | 4 |
23 | 28548087 | The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. | 2017 May 26 | 1 |
24 | 27173341 | Biological correlation between glucose transporters, Ki-67 and 2-deoxy-2-[18F]-fluoro-D-glucose uptake in diffuse large B-cell lymphoma and natural killer/T-cell lymphoma. | 2016 May 9 | 1 |
25 | 27218430 | Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma. | 2016 Oct | 1 |
26 | 27347132 | Expression and clinical significance of glucose transporter-1 in pancreatic cancer. | 2016 Jul | 1 |
27 | 25307508 | Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells. | 2015 Dec | 1 |
28 | 23701133 | Relationship between 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma. | 2014 Mar | 2 |
29 | 24365102 | Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer. | 2014 Feb | 4 |
30 | 24934577 | Significance of 18 F-FDG PET and immunohistochemical GLUT-1 expression for cardiac myxoma. | 2014 Jun 16 | 1 |
31 | 23674658 | 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. | 2013 Aug | 1 |
32 | 23699745 | Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization. | 2013 Jun | 1 |
33 | 24045262 | Factors affecting 18F-FDG uptake by metastatic lymph nodes in gastric cancer. | 2013 Sep-Oct | 1 |
34 | 24096997 | Glucose transporter 3 and 1 may facilitate high uptake of 18F-FDG in gastric schwannoma. | 2013 Nov | 1 |
35 | 26824929 | Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation. | 2013 Oct 29 | 2 |
36 | 22398711 | Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer. | 2012 May | 1 |
37 | 22408261 | The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines. | 2012 Apr 26 | 2 |
38 | 22901702 | Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma. | 2012 Nov | 1 |
39 | 20646779 | Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma. | 2011 Feb | 1 |
40 | 20884076 | Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size. | 2011 May | 1 |
41 | 24899993 | Intratumoral Heterogeneous F-18 Fluorodeoxyglucose Uptake Corresponds with Glucose Transporter-1 and Ki-67 Expression in a Case of Krukenberg Tumor: Localization of Intratumoral Hypermetabolic Focus by Fused PET/MR Image. | 2011 Jun | 1 |
42 | 24900002 | Impact of Lymphoid Follicles and Histiocytes on the False-Positive FDG Uptake of Lymph Nodes in Non-Small Cell Lung Cancer. | 2011 Sep | 1 |
43 | 20145577 | Gene expression and 18FDG uptake in atherosclerotic carotid plaques. | 2010 May | 2 |
44 | 20204293 | Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas. | 2010 Apr | 1 |
45 | 20540786 | The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients. | 2010 Jun 12 | 1 |
46 | 20703861 | Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer. | 2010 Aug | 1 |
47 | 19408578 | Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma. | 2009 | 1 |
48 | 19536037 | Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography. | 2009 Aug | 1 |
49 | 17640764 | Adenoid cystic carcinoma of the lung: interest of 18FDG PET/CT in the management of an atypical presentation. | 2008 Jan | 1 |
50 | 17653575 | 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. | 2008 Feb | 2 |